These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3039990)

  • 1. Ornithine transcarbamylase deficiency in spf and spf-ash mice: genes, mRNAs and mRNA precursors.
    Ohtake A; Takayanagi M; Yamamoto S; Nakajima H; Mori M
    Biochem Biophys Res Commun; 1987 Aug; 146(3):1064-70. PubMed ID: 3039990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of ornithine transcarbamylase deficiency in spf and spf-ash mutant mice.
    Ohtake A; Takayanagi M; Yamamoto S; Kakinuma H; Nakajima H; Tatibana M; Mori M
    J Inherit Metab Dis; 1986; 9(3):289-91. PubMed ID: 3099076
    [No Abstract]   [Full Text] [Related]  

  • 3. Compared expression levels of ornithine transcarbamylase and carbamylphosphate synthetase in liver and small intestine of normal and mutant mice.
    Dubois N; Cavard C; Chasse JF; Kamoun P; Briand P
    Biochim Biophys Acta; 1988 Sep; 950(3):321-8. PubMed ID: 3167057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of ornithine transcarbamylase (OTC) deficiency in small intestine for urinary orotic acid excretion: analysis of OTC-deficient spf-ash mice with OTC transgene.
    Saheki T; Mori K; Kobayashi K; Horiuchi M; Shige T; Obara T; Suzuki S; Mori M; Yamamura K
    Biochim Biophys Acta; 1995 Jan; 1270(1):87-93. PubMed ID: 7827141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between murine spf-ash mutation and genetic background yields different metabolic phenotypes.
    Marini JC; Erez A; Castillo L; Lee B
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1764-71. PubMed ID: 17925451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-free synthesis and transport of precursors of mutant ornithine carbamoyltransferases into mitochondria.
    Briand P; Miura S; Mori M; Cathelineau L; Kamoun P; Tatibana M
    Biochim Biophys Acta; 1983 Nov; 760(3):389-97. PubMed ID: 6626579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of mouse ornithine transcarbamylase deficiency by gene transfer into the germ line.
    Cavard C; Grimber G; Dubois N; Chasse JF; Bennoun M; Minet-Thuriaux M; Kamoun P; Briand P
    Nucleic Acids Res; 1988 Mar; 16(5):2099-110. PubMed ID: 3162766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient mitochondrial import of newly synthesized ornithine transcarbamylase (OTC) and correction of secondary metabolic alterations in spf(ash) mice following gene therapy of OTC deficiency.
    Zimmer KP; Bendiks M; Mori M; Kominami E; Robinson MB; Ye X; Wilson JM
    Mol Med; 1999 Apr; 5(4):244-53. PubMed ID: 10448647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retroviral-mediated gene transfer of human ornithine transcarbamylase into primary hepatocytes of spf and spf-ash mice.
    Grompe M; Jones SN; Loulseged H; Caskey CT
    Hum Gene Ther; 1992 Feb; 3(1):35-44. PubMed ID: 1562638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normalization of hair growth in sparse fur-abnormal skin and hair (SPF-ASH) mice by introduction of the rat ornithine transcarbamylase (OTC) gene.
    Shimada T; Tashiro M; Kanzaki T; Noda T; Murakami T; Takiguchi M; Mori M; Yamamura K; Saheki T
    J Dermatol Sci; 1994 Jul; 7 Suppl():S27-32. PubMed ID: 7999674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The spfash mouse: a missense mutation in the ornithine transcarbamylase gene also causes aberrant mRNA splicing.
    Hodges PE; Rosenberg LE
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4142-6. PubMed ID: 2471197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction of ornithine transcarbamylase deficiency in adult spf(ash) mice and in OTC-deficient human hepatocytes with recombinant adenoviruses bearing the CAG promoter.
    Kiwaki K; Kanegae Y; Saito I; Komaki S; Nakamura K; Miyazaki JI; Endo F; Matsuda I
    Hum Gene Ther; 1996 May; 7(7):821-30. PubMed ID: 8860834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive characterization of ureagenesis in the spf
    Allegri G; Deplazes S; Rimann N; Causton B; Scherer T; Leff JW; Diez-Fernandez C; Klimovskaia A; Fingerhut R; Krijt J; Kožich V; Nuoffer JM; Grisch-Chan HM; Thöny B; Häberle J
    J Inherit Metab Dis; 2019 Nov; 42(6):1064-1076. PubMed ID: 30714172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No increase of ornithine concentration in the liver of ornithine transcarbamylase-deficient spf-ash mice following intraperitoneal injection of ammonium chloride.
    Saheki T; Fukushige T; Kakinoki H; Kobayashi K
    Contrib Nephrol; 1997; 121():109-16. PubMed ID: 9336705
    [No Abstract]   [Full Text] [Related]  

  • 15. An Exon-Specific Small Nuclear U1 RNA (ExSpeU1) Improves Hepatic OTC Expression in a Splicing-Defective
    Balestra D; Ferrarese M; Lombardi S; Ziliotto N; Branchini A; Petersen N; Bosma P; Pinotti M; van de Graaf SFJ
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228018
    [No Abstract]   [Full Text] [Related]  

  • 16. Restoration of hepatic cytochrome c oxidase activity and expression with acetyl-L-carnitine treatment in spf mice with an ornithine transcarbamylase deficiency.
    Mawal YR; Rama Rao KV; Qureshi IA
    Biochem Pharmacol; 1998 Jun; 55(11):1853-60. PubMed ID: 9714304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ornithine transcarbamylase deficiencies in human males. Kinetic and immunochemical classification.
    Briand P; Francois B; Rabier D; Cathelineau L
    Biochim Biophys Acta; 1982 May; 704(1):100-6. PubMed ID: 7093283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced ornithine transcarbamylase activity does not impair ureagenesis in Otc(spf-ash) mice.
    Marini JC; Lee B; Garlick PJ
    J Nutr; 2006 Apr; 136(4):1017-20. PubMed ID: 16549467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticosteroid suppresses urea-cycle-related gene expressions in ornithine transcarbamylase deficiency.
    Imoto K; Tanaka M; Goya T; Aoyagi T; Takahashi M; Kurokawa M; Tashiro S; Kato M; Kohjima M; Ogawa Y
    BMC Gastroenterol; 2022 Mar; 22(1):144. PubMed ID: 35346058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrations of ammonia metabolism in ornithine carbamoyltransferase-deficient spf-ash mice and their prevention by treatment with urea cycle intermediate amino acids and an ornithine aminotransferase inactivator.
    Li MX; Nakajima T; Fukushige T; Kobayashi K; Seiler N; Saheki T
    Biochim Biophys Acta; 1999 Sep; 1455(1):1-11. PubMed ID: 10524224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.